Merck KGaA drops $1.3B on U.K. gene-silencing biotech for rare-disease bet
All-cash acquisition delivers divesiran, a late-stage-ready experimental treatment, to Merck KGaA's pipeline.

Loading the Newsroom
Curating from trusted global sources…
328 briefings · “ea”
All-cash acquisition delivers divesiran, a late-stage-ready experimental treatment, to Merck KGaA's pipeline.
The journalist who exposed Theranos says the Oscar-buzzed film is art, not evidence, and the distinction matters for anyone weighing a founder's story.
Expanding its X-energy deal, Amazon funds 12 unproven SMRs for Indiana, but no US small reactor is operating and the mid-2030s timeline is far from locked.
A federal judge ordered Abdulrahman Alfozan held without bail after prosecutors detailed WhatsApp chats with Saudi royalty and a military-booked flight for his family.
The Tel Aviv startup's code execution model formally verifies optimizations, turning AI into an agent for the hardware itself.
MIT team traces APOE4's damage to lipid droplets, opening a new drug target beyond amyloid and tau.
Amazon, Yelp, and Pizza Hut are blocking OpenAI's and Meta's new shopping agents, and a web optimized for bots could squeeze out the humans who built it.
The 2026 runway marked the Fantasy Bra's return after an eight-year hiatus, with Jenner wearing the priciest version ever. Here's how it stacks up against the $15 million record.
New global analysis finds 25% of data centers already face water stress for at least one month a year - and climate change could push that to one-third.
Nick Cammarata's Goodfire post has the AI world split - if he's right, monitoring frontier models just got a lot easier.
Delft's MonoRace won the 2025 Abu Dhabi Autonomous Racing League and beat three former world champions without GPS, a map, or motion capture.
The e-commerce giant is backing a 960-megawatt SMR fleet with X-energy and AEP, a high-stakes test for the AI data center power crunch.